anmelden
NYSE International 100
10.930,17
PKT
-14,10
PKT
-0,13
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.09.26 | Unilever Hold | Deutsche Bank AG | |
| 07.09.26 | Deutsche Bank Buy | Warburg Research | |
| 07.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 07.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 04.09.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.09.26 | TotalEnergies Overweight | Barclays Capital | |
| 04.09.26 | Eni Overweight | Barclays Capital | |
| 04.09.26 | BP Overweight | Barclays Capital | |
| 04.09.26 | AXA Outperform | RBC Capital Markets | |
| 04.09.26 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
| 04.09.26 | AXA Overweight | Barclays Capital | |
| 04.09.26 | Allianz Underweight | Barclays Capital | |
| 04.09.26 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 04.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 04.09.26 | Eni Sector Perform | RBC Capital Markets | |
| 04.09.26 | BP Outperform | RBC Capital Markets | |
| 04.09.26 | AXA Overweight | JP Morgan Chase & Co. | |
| 03.09.26 | Siemens Outperform | Bernstein Research | |
| 03.09.26 | Deutsche Telekom Overweight | Barclays Capital | |
| 03.09.26 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 02.09.26 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 02.09.26 | GSK Hold | Deutsche Bank AG | |
| 02.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 02.09.26 | Sanofi Buy | Deutsche Bank AG | |
| 02.09.26 | Novartis Buy | Deutsche Bank AG | |
| 02.09.26 | TotalEnergies Outperform | RBC Capital Markets | |
| 02.09.26 | Deutsche Bank Buy | Goldman Sachs Group Inc. | |
| 02.09.26 | Barclays Buy | Jefferies & Company Inc. | |
| 01.09.26 | Novartis Neutral | UBS AG | |
| 01.09.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 01.09.26 | Diageo Neutral | JP Morgan Chase & Co. | |
| 01.09.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 01.09.26 | UBS Outperform | RBC Capital Markets | |
| 31.08.26 | UBS Buy | Jefferies & Company Inc. | |
| 28.08.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 28.08.26 | Novartis Buy | Deutsche Bank AG | |
| 28.08.26 | Diageo Outperform | Bernstein Research |
